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patients with CAE compared with patients with 
and without significant atherosclerosis, using 
endocan and simple inflammatory and meta-
bolic markers.
Methods In this study, we consecutively en-
rolled 27 patients with CAE (CAE group) out of 
patients who underwent coronary angiography 
for suspected CAD. The diagnosis of CAE was 
based on the conventional definition of a coro-
nary artery dilation to a diameter of 1.5 times or 
more of the adjacent normal segment. The sec-
ond group included 27 age- and sex -matched 
patients with coronary artery stenosis great-
er than 70% and without CAE (CAD group). Fi-
nally, the third group included 27 age- and sex-
-matched participants with normal coronary ar-
teries (control group). We excluded patients with 
acute inflammatory disorders (high -sensitivity 
C -reactive protein >10 mg/l), active neoplastic 
disease, connective tissue diseases, thrombot-
ic and plasmatic diathesis, acute and chronic 
renal failure with a glomerular filtration rate 
of less than 30 ml/min, or allergy to iodinated 
contrast medium.
Blood samples were obtained 1 day after cor-
onary angiography. For blood serum collection, 
standard tubes with chemically neutral coag-
ulation activator (silicon dioxide as the main 
component) were used. Serum samples were 
obtained to determine routine laboratory pa-
rameters. Additionally, the ratios of monocyte 
to HDL -C, TG to HDL -C, and low -density li-
poprotein cholesterol (LDL-C) to HDL -C were 
assessed. The remaining serum was aliquoted, 
frozen, and stored at a temperature of –80°C. 
Introduction Coronary artery ectasia (CAE) 
is a dilation of the artery to the diameter of 
1.5-fold or more of the largest native coronary 
vessel.1 The incidence of CAE varies from 0.15% 
to 5.3% among coronary angiographies of pa-
tients diagnosed with coronary artery disease 
(CAD).2 The etiology of CAE has not been fully 
established yet. Lenihana et al3 observed that 
coronary aneurysms in adults younger than 33 
years of age are typically congenital, resulting 
from a defect of an internal elastic membrane 
and fibrillar proteins of the connective tissue. 
At an older age, secondary causes of CAE were 
predominant, such as atherosclerosis, vasculitis, 
or angiogenic disorders. The underlying mech-
anism is probably based on the enlargement of 
the artery lumen at the site of atherosclerotic 
lesions, compensating for atheromatous plaque 
buildup. One of the pathophysiologic factors is 
an immune–inflammatory response to endothe-
lial injury.2,4 Endocan, a proteoglycan secreted 
by the endothelium in response to inflammato-
ry cytokines, plays a crucial role in regulating 
major physiologic and pathophysiologic process-
es, such as cell adhesion, inflammation, and tu-
mor progression.4 Additionally, several readily 
available inflammatory and metabolic parame-
ters have been shown to be promising and were 
validated in other cardiac diseases, especially in 
ischemic heart disease. They include mean plate-
let volume (MPV),5 neutrophil -to -lymphocyte ra-
tio,6 platelet -to -lymphocyte ratio,7 and the ratio 
of triglycerides (TG) to high -density lipoprotein 
cholesterol (HDL -C).8
In this study, we sought to assess the severi-
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the control group. Similarly, metabolic disor-
ders such as reduced HDL -C, higher TG/HDL-
-C ratio, and monocyte/HDL -C ratio were more 
pronounced in the CAE and CAD groups than 
in the control group. The LDL-C/HDL-C ratio 
was significantly higher in patients with CAE 
than in those with CAD (Supplementary ma-
terial, Table S1).
The above inflammatory markers are readily 
available and promising parameters that have 
been validated in cardiac diseases. Elevated MPV 
levels are related to increased platelet activation 
and, in consequence, a higher risk of thrombot-
ic disorders and myocardial infarction, espe-
cially myocardial infarction with ST -segment 
elevation.5 Chen et al9 found elevated MPV lev-
els also in patients with coronary aneurysms 
in the course of Kawasaki disease. Interesting-
ly, Şarlı et al10 revealed significantly higher MPV 
levels only in patients with CAE coexisting with 
CAD. Isolated CAE was not associated with el-
evated MPV levels as compared with the con-
trol group.
The above results suggest that inflamma-
tion contributes to atherogenesis and, conse-
quently, to aneurysms. Another interesting 
finding was a significantly lower HDL -C lev-
el and higher TG/HDL -C ratio in the CAE and 
CAD groups, as compared with controls. An in-
crease in the TG/HDL -C ratio reflects an un-
favorable alteration in lipid profile, which has 
also been linked to insulin resistance and in-
cidents of ischemic heart disease.8 Sudhir et 
al11 demonstrated an increased prevalence of 
CAE in patients with heterozygous familial 
hypercholesterolemia and a strong correla-
tion between low HDL -C levels and a more fre-
quent incidence of ectasias. Our analysis also 
revealed a higher monocyte/HDL -C ratio in 
patients with coronary aneurysms compared 
with controls. Yildirim et al12 reported a sig-
nificant increase in the adhesion of monocyte 
and lymphocyte in the CAE group in compar-
ison with CAD and control groups. This find-
ing may reflect an increased intensity of in-
flammation and oxidative stress in CAE com-
pared with CAD.
Coronary artery ectasia is a rare phenome-
non; therefore, the number of patients in our 
study is limited. Due to the relatively small 
study group and potentially complex etiolo-
gy of CAEs, further research is needed to con-
firm our findings.
In conclusion, the majority of aneurysms in 
adults coexist with significant atherosclero-
sis. Almost all of the studied parameters were 
elevated in patients with CAE and CAD com-
pared with controls. This is most likely due 
to the atherosclerotic etiology of most aneu-
rysms. Therefore, there is still a need to in-
vestigate additional risk factors for the for-
mation of CAEs.
Endocan was measured using Human Endothe-
lial cell -specific Molecule 1 (ECSM1/ENDOCAN) 
ELISA Kit (DRG MedTek, Springfield, New Jer-
sey, United States). The analysis was performed 
in the laboratory of the Department of Clinical 
Pharmacology at Poznan University of Medical 
Sciences (Poznań, Poland).
Statistical analysis was performed with 
the STATISTICA 12.0 software (StatSoft, Tul-
sa, Oklahoma, United States). The normal-
ity of variable distribution was tested with 
the Shapiro–Wilk test. Descriptive analysis, 
Kruskal–Wallis test, analysis of variance, and 
Mann–Whitney test were used for comparisons 
between groups. Differences with a P value of 
less than 0.05 were considered significant.
Results and discussion The baseline char-
acteristics of the study groups are presented 
in TABLE 1. The prevalence of cardiovascular risk 
factors such as age, sex, hypertension, or di-
abetes did not differ between groups. Ecta-
sias were most often located in the right cor-
onary artery and left anterior descending ar-
tery (53.5% and 48.8%, respectively). Diffuse 
ectasias were significantly more frequent than 
localized aneurysms (60.5% and 33.4%, re-
spectively). Significant stenosis of the coro-
nary arteries was diagnosed in 60.5% of pa-
tients with CAE. The level of endocan did not 
differ significantly between groups. Howev-
er, we found significantly elevated MPV both 
in the CAE and CAD groups compared with 
TABLE 1 Clinical characteristics of the study groups
Parameter CAE group 
(n = 27)
CAD group  
(n = 27)
Control group  
(n = 27)
P valuea
Male sex 20 (74.1) 20 (74.1) 20 (74.1) 1
Age, y 64 (59–68) 67 (63–70) 64 (58–69) 0.19







Hypertension 23 (85.2) 20 (74.1) 19 (70.4) 0.55
Hyperlipidemia 17 (63) 13 (48.1) 14 (51.8) 0.69
Diabetes 8 (30) 13 (48.1) 8 (29.6) 0.18
Previous MI 12 (44.4) 11 (40.7) 5 (18.5) 0.1
Smoking 5 (18.5) 1 (4) 5 (18.5) 0.07
Antiplatelet 
therapy
24 (89) 24 (89) 20 (74.1) 0.36
ACEIs 22 (81.5) 20 (74.1) 19 (70.4) 0.63
β­‑blockers 22 (81.5) 20 (74.1) 20 (74.1) 0.76
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